Graham Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
77,908
+58,891
| +310% | +$3.24M | 0.06% | 141 |
|
|
2025
Q1 | $1.34M | Buy |
+19,017
| New | +$1.34M | 0.02% | 438 |
|
|
2024
Q4 | – | Sell |
-13,038
| Closed | -$916K | – | 1213 |
|
|
2024
Q3 | $916K | Buy |
13,038
+5,709
| +78% | +$401K | 0.02% | 456 |
|
|
2024
Q2 | $603K | Sell |
7,329
-14,453
| -66% | -$1.19M | 0.01% | 502 |
|
|
2024
Q1 | $1.9M | Buy |
+21,782
| New | +$1.9M | 0.04% | 241 |
|
|
2023
Q3 | – | Sell |
-40,223
| Closed | -$3.49M | – | 1011 |
|
|
2023
Q2 | $3.49M | Buy |
+40,223
| New | +$3.49M | 0.1% | 126 |
|
|
2022
Q4 | – | Sell |
-31,003
| Closed | -$2.63M | – | 1051 |
|
|
2022
Q3 | $2.63M | Buy |
31,003
+26,503
| +589% | +$2.25M | 0.1% | 145 |
|
|
2022
Q2 | $372K | Sell |
4,500
-12,977
| -74% | -$1.07M | 0.02% | 753 |
|
|
2022
Q1 | $1.35M | Buy |
17,477
+14,056
| +411% | +$1.08M | 0.05% | 202 |
|
|
2021
Q4 | $302K | Buy |
+3,421
| New | +$302K | 0.01% | 314 |
|